Athena Diagnostics, Nanogen deal

NGEN received a worldwide non-exclusive license from Athena to IP covering the use of Apolipoprotein E (ApoE) isoforms to diagnose and monitor Alzheimer's disease (AD). NGEN plans to develop a kit th...